Corbus Pharmaceuticals corbuspharma.com


Public lists: Pharma Startups (4733)

Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic diseases with clear unmet needs. The company's lead product Resunab is a first- in-class oral anti-inflammatory expected to commence Phase-2a clinical trials for the treatment of cystic fibrosis and scleroderma pending FDA approval of INDs to be filed in the second half of 2014.

Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic diseases with clear unmet needs. The company's lead...Show all

Company (IPO / Went public)

Phone: 617-413-3020

Fax:

One Kendall Square
Bldg 200
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Corbus Pharmaceuticals $6.4M Oct 28, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Corbus Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Ultrapure tetrahydrocannabinol-11-oic acids Nov 09, 2016 Nov 21, 2017 Patent
Ultrapure tetrahydrocannabinol-11-oic acids Nov 09, 2016 Oct 31, 2017 Patent
Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids Jun 09, 2017 Application
Compositions, dosages, and methods of using tetrahydrocannabinol derivatives Oct 03, 2016 Application
Ultrapure tetrahydrocannabinol-11-oic acids Jul 26, 2016 Application
See all 7 patents